Randomised Controlled Clinical Trial of Cognitive Rehabilitation in Multiple Sclerosis
NCT01207856 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2016-02-09
Summary
Despite the need for cognitive rehabilitation, there is a paucity of well-designed research studies to investigate treatment approaches or their effectiveness in MS. Most of published studies suffer from significant methodological flaws including small sample size, short follow-up periods, and lack of specific outcome criteria to determine improvement. O'Brien et al. (2008) recently reviewed 16 studies of cognitive rehabilitation designed to persons with MS and found only 4 class I studies and only one class I study of rehabilitation of attention deficits. Methodologically rigorous research is needed to confirm the preliminary results reported by these studies and determine the effectiveness and efficacy of cognitive rehabilitation interventions in attention deficits in MS. O'Brien et al. listed limitations found in previous studies that must be addressed in future studies. The present study was designed according to these recommendations. It is a randomized, controlled study, in parallel groups, evaluator blinded.
Number of participants: 25 RRMS patients in the active group, 25 RRMS patients in the control group and 25 healthy subjects.
The protocol will be proposed to RRMS patients AFFILIATED TO FRENCH SOCIAL SECURITY referred to the investigators center by practicing neurologists and fulfilling the inclusion criteria for screening.
Patients will be randomised between two groups. The active group (25 patients) will be treated by rehabilitation. Individual rehabilitation procedures will be focused on attention, executive functions and IPS. The program will be tailored to each patient cognitive status depending on the impairments identified during the initial assessment while maintaining a systematic work on attention and executive functions. A total of 50 sessions lasting one hour at a rate of 3 sessions per week for a total period of 4 months will be proposed. Patients randomized in the other group will participate to group session every week without specific cognitive rehabilitation. 25 healthy control subjects (group C), matched to patients for education, gender and age with patients of groups A/B will have the same evaluation procedures than patients.
Evaluation will be performed at baseline, after 4 months (end of treatment period) and after 8 months. Evaluation will include clinical testing, cognitive battery (paper/pencil and computer tests), cognitive ecological evaluation (Computer test of attention in a virtual reality environment and driving test on a driving simulator), questionnaires about daily life and MRI (fMRI and MRI). All patients and healthy subjects will undergo the fMRI protocol using a paradigm previously published by the investigators group (Bonnet et al., 2009): Go/No-go paradigm with increasing difficulty during four successive conditions (the Tonic Alertness task, Go/No-go (IG), reversal Go/No-go (RG), and complex Go/No-go (CG). In a previous study the investigators observed compensatory activation in MS patients as compared to healthy controls for the three first conditions and a saturation of compensatory processes for the more complex. In the present study, the investigators hypothesize that a similar pattern will occur at baseline and that cognitive rehabilitation will improve brain compensation at the fourth level of complexity.
Conditions
- Multiple Sclerosis
- Cognitive Rehabilitation
Interventions
- BEHAVIORAL
-
specific cognitive rehabilitation
Individual rehabilitation procedures will be focused on attention, executive functions, IPS and working memory. The program will be tailored to each patient cognitive status depending on the impairments identified during the initial assessment while maintaining a systematic work on attention and executive functions. A total of 50 sessions lasting one hour at a rate of 3 sessions per week for a total period of 4 months will be proposed. Sessions will include varied exercises according to complexity and presentation modality, using computerized and "paper-and-pencil" tasks and metacognitive training. Work will be progressive, depending on the progresses achieved (increase complexity and intensity of the exercises according to success at the previous level of exercises).
- BEHAVIORAL
-
non specific cognitive rehabilitation
A total of 50 sessions lasting one hour at a rate of 3 sessions per week for a total period of 4 months will be proposed by group composed to 5 patients
- OTHER
-
no intervention
no intervention
Sponsors & Collaborators
-
Merck Serono International SA
collaborator INDUSTRY -
ARSEP foundation
collaborator UNKNOWN -
University Hospital, Bordeaux
lead OTHER
Principal Investigators
-
Bruno Brochet, Md PhD · University Hospital, Bordeaux
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2015-07-31
- Completion
- 2016-02-29
Countries
- France
Study Locations
More Related Trials
-
Rehabilitative Protocols in Progressive Multiple Sclerosis Treated with Anti CD20 Monoclonal Antibodies
NCT06894940 ·Status: COMPLETED ·Phase: PHASE2
-
Targeting Subclinical Motor and Cognitive Impairment in Patients With Early Onset Multiple Sclerosis
NCT06303024 ·Status: RECRUITING ·Phase: NA
-
Metacognition Assessment in Patient With Multiple Sclerosis
NCT04240379 ·Status: COMPLETED
-
Social Cognition in Multiple Sclerosis, From a Study of Eye Movement and Gaze Strategies Using Video-oculography
NCT04705610 ·Status: COMPLETED ·Phase: NA
-
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
NCT04233970 ·Status: COMPLETED ·Phase: NA
-
Screening for Cognitive Disorders in Multiple Sclerosis
NCT07030036 ·Status: NOT_YET_RECRUITING
-
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
NCT02137044 ·Status: COMPLETED ·Phase: NA
-
Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis
NCT02287454 ·Status: COMPLETED ·Phase: NA
-
Intellectual Enrichment to Build Cognitive Reserve in MS
NCT01978574 ·Status: COMPLETED ·Phase: NA
-
Function Magnetic Resonance Imaging to Assess Two Therapeutic Strategies in Multiple Sclerosis (NeuroRehEM).
NCT05270239 ·Status: COMPLETED ·Phase: NA
-
Self-compassion for People with Multiple Sclerosis: an Exploratory Feasibility Study
NCT06337903 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Understanding Magnetic Resonance Imaging in Multiple Sclerosis
NCT03872583 ·Status: COMPLETED ·Phase: NA
-
Cognition and MRI Markers in MS Patients With Aubagio® Treatment
NCT03768648 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Adherence of Multiple Sclerosis Patients
NCT04837352 ·Status: RECRUITING
-
Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
NCT01392872 ·Status: COMPLETED ·Phase: NA
-
Don't be Late! Postponing Cognitive Decline and Preventing Early Unemployment in People With Multiple Sclerosis
NCT06068582 ·Status: RECRUITING ·Phase: NA
-
Consolidation & Interference in Multiple Sclerosis
NCT02081508 ·Status: COMPLETED ·Phase: NA
-
MS-NEUROPLAST: Neuroplasticity of Cortical Areas Induced by Cognitive Training in Patients with Multiple Sclerosis
NCT04806568 ·Status: RECRUITING ·Phase: NA
-
Treating New Learning and Memory Deficits in Progressive Multiple Sclerosis (MS)
NCT02301247 ·Status: COMPLETED ·Phase: NA
-
Home-based Action Observation Treatment With Virtual-reality for Arm Rehabilitation in People With Multiple Sclerosis
NCT05713890 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)
NCT00001248 ·Status: RECRUITING
-
MRI Study of the Mechanisms Underlying Irreversible Disability in Multiple Sclerosis
NCT03356366 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Digital Cognition in Multiple Sclerosis
NCT03569618 ·Status: COMPLETED ·Phase: NA
-
Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients
NCT04694534 ·Status: RECRUITING ·Phase: NA
-
Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis
NCT00097331 ·Status: COMPLETED ·Phase: PHASE2